Annual Meeting

Different field, different problem, same solution: metabolism!

A Discover BMB symposium: Advances in Organismal and Cellular Metabolism
Gary Patti Nika Danial
By Gary Patti and Nika Danial
Sept. 20, 2022

Metabolism has captured the interest of researchers across many different biological disciplines. In some fields, interest in longstanding metabolic questions has been renewed. In other areas, new metabolic connections are being made for the first time. No matter the topic, however, metabolism studies evoke pathway charts and methodological approaches that may not be common knowledge in all disciplines, and this could hinder dialogue between investigators. Moreover, many of the same metabolic patterns are observed consistently in different disease settings, animal models and cell types. 

The purpose of our symposium at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held in March in Seattle, is to bring together researchers from disparate areas of biology who speak the common language of metabolism. We want to facilitate interactions between investigators who may be thinking about the same metabolic themes, but who are not typically at the same meetings or conferences. The presentations will not be organized by discipline but rather by metabolism topic, with the aim of stimulating new discussions and collaborative opportunities.

Our symposium will feature research examining metabolism at multiple levels — ranging from whole body to cells and organelles. We will hear how the same metabolic programs are implicated not only in diseases such as cancer and neurodegeneration but also in fundamental biochemical processes including immune response and vision.

Keywords: Metabolism, metabolomics, lipids, physiology, interorgan communication, mitochondria, lysosomes, isotope tracing.

Who should attend: Anyone interested in metabolism at any level in any context.

Theme song: “What Makes You Beautiful” by One Direction, because metabolism lights up all of our worlds — and in honor of the infamous “What Makes Glycolysis” parody (look it up!).

This session is powered by ox phos (platinum-level sponsor) and substrate-level phosphorylation (gold-level sponsor).

Speakers

Metabolic physiology
Gary Patti (chair), Washington University in St. Louis
Deb Muoio, Duke University
Nada Kalaany, Harvard Medical School
Matt Gentry, University of Kentucky

Metabolism in health and disease
Jason Tennessen, Indiana University
Jing Fan, University of Wisconsin

Organelle metabolism
Nika Danial (chair), Harvard Medical School
Dale Abel, University of California, Los Angeles
Roberto Zoncu, University of California, Berkeley
Natalie Niemi, Washington University in St. Louis
 

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Gary Patti
Gary Patti

Gary Patti is a professor in the departments of chemistry and medicine at Washington University in St. Louis and the senior director of the Center for Metabolomics and Isotope Tracing.

Nika Danial
Nika Danial

Nika Danial is an associate professor of medicine at Dana–Farber Cancer Institute and Harvard Medical School and the co-director of the T32 training program in cancer chemical biology and metabolism at DFCI.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
Journal News

Key regulator of cholesterol protects against Alzheimer’s disease

Feb. 24, 2026

A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.

From humble beginnings to unlocking lysosomal secrets
Award

From humble beginnings to unlocking lysosomal secrets

Feb. 20, 2026

Monther Abu–Remaileh will receive the ASBMB’s 2026 Walter A. Shaw Young Investigator Award in Lipid Research at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.

Chemistry meets biology to thwart parasites
Award

Chemistry meets biology to thwart parasites

Feb. 19, 2026

Margaret Phillips will receive the Alice and C. C. Wang Award in Molecular Parasitology at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.

ASBMB announces 2026 JBC/Tabor awardees
Award

ASBMB announces 2026 JBC/Tabor awardees

Feb. 18, 2026

The seven awardees are first authors of outstanding papers published in 2025 in the Journal of Biological Chemistry.